NCT02642913 Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients Status COMPLETED Phase PHASE1
NCT02626312 Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02616926 Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT02595866 Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Status COMPLETED Phase PHASE1
NCT02587884 Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH Status UNKNOWN Phase PHASE1
NCT02587793 Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients Status COMPLETED Phase N/A
NCT02587689 Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT02586285 Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT02585687 Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma Status TERMINATED Phase NA
NCT02585479 Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2/PHASE3
NCT02584556 Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2/PHASE3
NCT02580253 Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation Status WITHDRAWN Phase PHASE2
NCT02576509 An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02575339 MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02572687 A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Status COMPLETED Phase PHASE1
NCT02564666 The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib Status UNKNOWN Phase NA
NCT02562963 Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor Status UNKNOWN Phase PHASE1/PHASE2
NCT02558205 Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry Status WITHDRAWN Phase N/A